Many studies of Mycobacterium tuberculosis infection and immunity have used mouse
models. However, outcomes of vaccination and challenge with M. tuberculosis in inbred …

Tuberculosis (TB) is a bacterial infectious disease that comes with a high mortality rate
through manifesting lung damage. Understanding the TB transmission is critical to designing …

The Mycobacterium bovis BCG vaccine was first used in 1921, but has not controlled the
global spread of tuberculosis (TB). There are still no new licensed tuberculosis vaccines …

Tuberculosis remains a major source of morbidity and mortality worldwide, with 10 million
cases and 1.5 million deaths in 2018. Achieving 'End TB'prevention and care goals by 2035 …

Mycobacterium tuberculosis remains the leading cause of death attributed to a single
infectious organism. Bacillus Calmette-Guerin (BCG), the standard vaccine against M …

Tuberculosis (TB) is still the leading global cause of death from an infectious bacterial agent.
Limiting tuberculosis epidemic spread is therefore an urgent global public health priority. As …

Key Points HIV-Associated Tuberculosis Almost half of inpatients with human
immunodeficiency virus (HIV)–associated tuberculosis in countries with a high disease …

Tuberculosis is still problematic as it affects large numbers of people globally.
Mycobacterium tuberculosis Lineage 1 (L1) or Indo Oceanic Lineage, one of widespread …

China is one of the countries with a high burden of tuberculosis (TB) and latent tuberculosis
infection (LTBI). It was recently estimated that China had the highest LTBI burden in the …

Despite over a century of research, Mycobacterium tuberculosis (Mtb), the causative agent of
tuberculosis (TB), continues to kill 1.5 million people annually. Though less than 10% of …